Africure Pharmaceuticals Ltd Stock

AFRP.N0000

MU0713N00001

End-of-day quote Mauritius S.E. 2026-08-21			5-day change	1st Jan Change
6.060 ^USD	0.00%		0.00%	-

08-07	Africure Pharmaceuticals Ltd Announces Extension of Deadline to Release Unaudited Financial Results	CI
06-22	Africure Pharmaceuticals Ltd Delays Earnings Results Release for the Year Ended March 31, 2026	CI

Chart: Africure Pharmaceuticals Ltd

Dynamic Chart

Latest news : Africure Pharmaceuticals Ltd

08-07	Africure Pharmaceuticals Ltd Announces Extension of Deadline to Release Unaudited Financial Results	CI
06-22	Africure Pharmaceuticals Ltd Delays Earnings Results Release for the Year Ended March 31, 2026	CI
25-08-07	Africure Pharmaceuticals Ltd Announces Delay in the Interim Results for the Three Months Ended 30 June 2025	CI
25-02-10	Africure Pharmaceuticals Ltd Announces Delay in Publication of Unaudited Financial Statements for the Three Months and Nine Months Ended 31 December 2024	CI

More news

Press Releases: Africure Pharmaceuticals Ltd

25-02-10

Africure Pharmaceuticals : Communique

More press releases

Managers and Directors: Africure Pharmaceuticals Ltd

Manager	Title	Age	Since
Sinhue Bosco Noronha CEO	Chief Executive Officer	66	2017-03-21
Ravi Shankar Chandrasekhar DFI	Director of Finance/CFO	43	2017-03-21

Director	Title	Age	Since
Sinhue Bosco Noronha BRD	Director/Board Member	66	2017-03-21
Ravi Shankar Chandrasekhar BRD	Director/Board Member	43	2017-03-21
Sultunti Asnath BRD	Director/Board Member	51	2017-03-16

More insiders

Africure Pharmaceuticals Limited is specialized in manufacturing and marketing generic medicines. The group offers antibiotics, anti-inflammatories, analgesics, antivirals, antimalarials, etc. At the end of March 2024, the group had 5 production sites located in India, Cameroon, Botswana, Côte d'Ivoire, Tanzania, and Ethiopia.

Employees

Sector

More about the company